These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6567478)
1. Antitumor and antimetastatic activity of the immunoadjuvant peptidoglycan monomer PGM in mice bearing MCa mammary carcinoma. Sava G; Tomasic J; Hrsak I Cancer Immunol Immunother; 1984; 18(1):49-53. PubMed ID: 6567478 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM). Sava G; Giraldi T; Tomasić J; Hrsak I Cancer Immunol Immunother; 1983; 15(2):84-6. PubMed ID: 6553516 [TBL] [Abstract][Full Text] [Related]
3. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt. Sava G; Zorzet S; Perissin L; Lassiani L; Tomasic J Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):477-80. PubMed ID: 4079598 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of B-16 melanoma with peptidoglycan monomer. Hrsak I; Tomasić J; Osmak M Eur J Cancer Clin Oncol; 1983 May; 19(5):681-6. PubMed ID: 6683639 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse. Tomasić J; Hanzl-Dujmović I; Spoljar B; Vranesić B; Santak M; Jovicić A Vaccine; 2000 Jan; 18(13):1236-43. PubMed ID: 10649625 [TBL] [Abstract][Full Text] [Related]
6. Relationship of metabolism and immunostimulating activity of peptidoglycan monomer in mice after three different routes of administration. Valinger Z; Ladesić B; Hrsak I; Tomasić J Int J Immunopharmacol; 1987; 9(3):325-32. PubMed ID: 3610420 [TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro modulation of NK and ADCC activities of mouse spleen cells by peptidoglycan monomer (PGM). Gabrilovac J; Tomasić J; Boranić M; Martin-Kleiner I; Osmak M Res Exp Med (Berl); 1989; 189(4):265-73. PubMed ID: 2813963 [TBL] [Abstract][Full Text] [Related]
8. Comparative susceptibility of a peptidoglycan monomer from Brevibacterium divaricatum and its anhydromuramyl analogue to hydrolysis with N-acetylmuramyl-L-alanine amidase. Isolation and characterization of anhydromuramyl-peptidoglycan monomer. Tomasić J; Sesartić L; Martin SA; Valinger Z; Ladesić B J Chromatogr; 1988 May; 440():405-14. PubMed ID: 2900248 [TBL] [Abstract][Full Text] [Related]
9. The metabolic fate of 14C-labeled immunoadjuvant peptidoglycan monomer. II. In vitro studies. Ladesić B; Tomasić J; Kveder S; Hrsak I Biochim Biophys Acta; 1981 Nov; 678(1):12-7. PubMed ID: 6118181 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of peptidoglycan monomer and its metabolic products. Halassy B; Krstanović M; Frkanec R; Tomasić J Vaccine; 2003 Feb; 21(9-10):971-6. PubMed ID: 12547610 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of an immunomodulator peptidoglycan monomer in mice after intravenous administration. Ladesić B; Perović S; Hrsak I Int J Immunopharmacol; 1993 Feb; 15(2):145-50. PubMed ID: 8468117 [TBL] [Abstract][Full Text] [Related]
12. Side-effects of peptidoglycan monomer (PGM) treatment in mice. Sverko V; Marotti T; Gavella M; Lipovac V; Hrsak I Immunopharmacology; 1994; 28(3):193-9. PubMed ID: 7852050 [TBL] [Abstract][Full Text] [Related]
13. Immunoregulating effects of peptidoglycan monomer linked with zinc in adult mice. Radoŝević-Staŝić B; Trobonjaĉa Z; Petković M; Milin C; Cuk M; Muhvić D; Ravlić-Gulan J; Marić I; Rukavina D Int Arch Allergy Immunol; 1995 Mar; 106(3):219-28. PubMed ID: 7888784 [TBL] [Abstract][Full Text] [Related]
14. Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties. Sava G; Pacor S; Mestroni G; Alessio E Clin Exp Metastasis; 1992 Jul; 10(4):273-80. PubMed ID: 1617835 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the antimetastatic effects of synthetic muramyl tripeptide (CGP 19835A) encapsulated in liposomes in combination with other immunomodulatory agents and chemotherapeutic drugs. Bezault J; Walsh C; Tarcsay L; Frost H; Liebes L; Furmanski P In Vivo; 1993; 7(6A):487-91. PubMed ID: 8193265 [TBL] [Abstract][Full Text] [Related]
16. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide]. Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870 [No Abstract] [Full Text] [Related]
17. Augmentation of NKT and NK cell-mediated cytotoxicity by peptidoglycan monomer linked with zinc. Mrakovcić-Sutić I; Radosević-Stasić B; Simin M; Muhvić D; Rukavina D Mediators Inflamm; 2002 Apr; 11(2):129-35. PubMed ID: 12061425 [TBL] [Abstract][Full Text] [Related]
18. [Antimetastatic effect of a liposome-enclosed analog of muramyl dipeptide]. Umanskiĭ VIu; Stefanov AV; Bondar' OP; Balitskiĭ KP; Pinchuk VG Vopr Onkol; 1988; 34(4):433-8. PubMed ID: 2837005 [TBL] [Abstract][Full Text] [Related]
19. [Immunomodulators of microbial origin enhance cytotoxicity of human mononuclear leukocytes and reduce metastatic progression of Lewis lung carcinoma in mice]. Akhmatova NK; Semenova IB; Donenko FV; Kiselevskiĭ MV; Kurbatova EA; Egorova NB Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):35-40. PubMed ID: 17163136 [TBL] [Abstract][Full Text] [Related]
20. MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumours in mice. Yoo YC; Saiki I; Sato K; Azuma I Vaccine; 1994 Feb; 12(2):175-60. PubMed ID: 8147100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]